NICE has published draft guidance restricting use of antibiotics in patients with chronic obstructive pulmonary disease (COPD), as in many cases the treatment is inappropriate and could lea
The UK's NICE endorsed regular NHS funding for big-selling drugs from Roche and Sanofi, changing its mind in guidance for the multiple sclerosis and eczema drugs.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
